Osteoarthritis of the Knee Pain Study Using a CBD and THC Sublingual Tablet

March 7, 2018 CBD Products

Back to all posts

Collaborator: Policy Lab U.S
Link

Summary:
This study is a prospective Phase 2, drug controlled, dose-controlled study to evaluate the safety and efficacy of Pure Green sublingual tablets for the treatment of pain associated with osteoarthritis of the knee.
Recruitment Status: Recruiting
Study Details:
Sponsor: Pure Green
Information provided by (Responsible Party): Pure Green
Condition or Disease: Osteoarthritis, Knee Pain
Intervention/ Treatment: Drug: Test Article
Phase: Phase 2
Study Type: Interventional (Clinical Trial)
Estimated Enrolment: 30 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: A Dose Controlled Osteoarthritis of the Knee Pain Study Using CBD and THC in Rapidly Dissolvable Sublingual Tablet
Estimated Study Start Date: December 9, 2019
Estimated Primary Completion Date: February 1, 2020
Estimated Study Completion Date: April 1, 2020

CBD Products

See all posts by CBD Products

You may also like

Browse our Clinical Trials

See posts

Participate in CBD Research

CBD World News is part of an active community, working to enhance our understanding of the benefits of CBD. You can become an active part of that community too, by taking part in our collaborative research. We are interested in finding out who is using CBD, how it is used, and what it is used for?

Taking part in this research will help bring the good word of CBD to life and help people all over the world discover the benefits of cannabinoids.

Take our survey

CBD World News is Social!

Follow our latest adventures on Facebook, Instagram, and Twitter as we meet the people and producers who make the industry what it is.